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patients. In recent years, the number of patients with
renal disease who will have coronary artery disease
amenable to surgical revascularization is likely to
increase. Patients receiving long-term hemodialysis are
at a high risk for both mortality and morbidity after car-
diac surgery. Performing cardiac surgery in these
patients can be challenging. Close teamwork among the
cardiac surgeon, anesthesiologist, nephrologist, and
cardiologist is essential.
Cardiopulmonary bypass (CPB) has been used with
increasing frequency in hemodialysis-dependent
patients since a 1968 report by Lansing, Leb, and
Berman.1 The initial reports were case presentations.2,3
Numerous reports have described the results of heart
surgery in patients with end-stage CRF.4-10 However,
few studies have evaluated the results of heart surgery
in patients with non–dialysis-dependent, mild renal
insufficiency.11-13
In this study, we retrospectively reviewed our experi-
C hronic renal failure (CRF) in which glomerular fil-tration is progressively and irreversibly damaged is
an important risk factor for the development of heart
diseases. Patients with CRF have an accelerated rate of
atherosclerosis, and death rates owing to cardiac dis-
ease increase dramatically with age in these patients.
Because of improved diagnostic and therapeutic
capabilities, life expectancy was increased in these
Objective: Renal failure is known to increase the morbidity and mortali-
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group II. On multivariable logistic regression analysis, risk factors for
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ence with heart surgery in patients with dialysis-depen-
dent or non–dialysis-dependent renal failure, with par-
ticular emphasis on the predictor of mortality and
morbidity.
Patients and methods
From a population of 4855 consecutive patients undergoing
heart surgery in the Department of Cardiovascular Surgery at
Ege University Medical Faculty between January 1993 and
June 1998, 119 patients with preoperative renal failure were
identified (2.45%). There were 108 (90.7%) male and 11
(9.2%) female patients. The mean age was 59 ± 12 (range 20-
87 years). The patients were divided into 3 groups. Group I
consisted of 93 patients with creatinine levels between 1.6
and 2.5 mg/dL, but who were not receiving hemodialysis or
peritoneal dialysis. Group II consisted of 18 patients with cre-
atinine levels greater than 2.5 mg/dL who were not undergo-
ing dialysis. Group III consisted of 8 patients with end-stage
renal disease who were receiving hemodialysis (Table I).
Informed consent was obtained from all patients. 
Ninety-one patients had coronary artery disease (76.5%).
Other cardiac diseases included mitral valve disease in 12
(10.1%) patients, aortic valve disease in 5 (4.3%), double
valve disease in 4 (3.5%), and thoracic aortic disease in 10
(8.4%). Hypertension was present in 58 patients. Diabetes
mellitus, peripheral vascular disease, and chronic obstructive
lung disease were the other additional comorbid diseases.
Five patients had prior nephrectomy. Associated comorbid
diseases and risk factors are listed in Table II. 
Hemodialysis was performed in all patients in group III 16
to 24 hours before the operation. The patients with diseases
of the ascending aorta and/or aortic arch were operated on
with the aid of deep hypothermic total circulatory arrest. In
other patients, CPB was instituted with standard techniques.
A membrane oxygenator and roller pump were used in all
patients. A bovine heparin dose of approximately 300 IU/kg
Table I. Patients demographics and preoperative variables (mean ± SD)
Total, No. Group I, No. (%) Group II, No. (%) Group III, No. (%) Statistical significance
No. of patients 119 93 (78.2) 18 (15.1) 8 (6.7)
Sex
Male 108 (90.7) 85 (91.4) 16 (88.9) 7 (87.5)
Female 11 (9.3) 8 (8.6) 2 (11.1) 1 (12.5)
Age (y) 59 ± 12 60 ± 12 59 ± 13 54 ± 10 c 2 = 2.8, P = .2*
BSA (m2) 1.78 ± 0.18 1.77 ± 0.18 1.80 ± 0.19 1.75 ± 0.14 c 2 = 1.34, P =.5*
Cardiac disease 
CAD 91 (76.0) 72 (75.8) 12 (63.2) 7 (87.5)
Valvular disease 21 (16.8) 16 (16.8) 5 (26.3) 0 (0.0)
Aortic disease 9 (7.2) 7 (7.4) 2 (10.5) 1 (12.5)
LVEF (%) 46 ± 11 47 ± 11 45 ± 12 48 ± 11 c 2 = 1.16, P = .6*
Angina class
I 11 (9.2) 8 (8.6) 2 (11.1) 1 (12.5)
II 73 (61.3) 59 (63.4) 10 (55.6) 4 (50.0)
III 23 (19.3) 17 (18.3) 4 (22.2) 2 (25.0)
IV 12 (10.2) 9 (9.7) 2 (11.1) 1 (12.5)
BSA, Body surface area; CAD, coronary artery disease; LVEF, left ventricular ejection fraction.
*Kruskal-Wallis test.
Table II. Associated comorbid diseases and risk factors
Group I, No. (%) Group II, No. (%) Group III, No. (%) Statistical significance
DM 18 (19.3) 4 (22.2) 2 (25.0) c 2 = 0.2, P = .9
Hypertension 47 (50.5) 8 (44.4) 3 (37.5) c 2 = 0.38, P = .95 
COPD 4 (4.3) 1 (5.6) 0 (0.0) P = .6
PVD 11 (11.8) 3 (16.6) 1 (12.5) c 2 = 0.32, P = .8
AAA 1 (1.1) 0 (0.0) 1 (12.5) P = .15
CVD 3 (3.2) 1 (5.6) 0 (0.0) c 2 = 0.38, P = .95
Prior nephrectomy 2 (2.1) 2 (11.1) 1 (12.5) c 2 = 4.48, P = .11
Prior MI 33 (35.5) 7 (38.9) 2 (25.0) c 2 = 0.47, P = .8
Unstable AP 9 (9.6) 2 (11.1) 1 (12.5) c 2 = 1.14, P = .6
Emergency 6 (6.5) 3 (16.6) 1 (12.5) c 2 = 2.23, P = .3
DM, Diabetes mellitus; COPD, chronic obstructive pulmonary disease; PVD, peripheral vascular disease; AAA, abdominal aortic aneurysm; CVD, cerebrovascular
disease; MI, myocardial infarction; AP, angina pectoris.
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was given before cannulation. Activated clotting time was
maintained higher than 480 seconds during the procedure.
Patients were cooled to a rectal temperature of 28˚C, and top-
ical myocardial cooling was accomplished with pericardial
lavage with cold saline solution. During CPB the hematocrit
level was maintained between 0.20 and 0.25, pump flow rates
between 2.0 and 2.5 L · min–1 · m–2, and mean arterial pressure
about 65 mm Hg. Blood cardioplegia was used for myocardial
protection. The cardioplegic solution was delivered either in an
antegrade fashion via the aortic root or coronary ostium or in a
retrograde fashion via the coronary sinus. A dopamine infusion
(3 µg · kg–1 · min–1) was started before CPB to improve renal
perfusion in patients in groups I and II. Heparin was reversed
by protamine sulfate after decannulation. Ultrafiltration was
used in all patients in group III after CPB. 
The operative procedures used were coronary artery bypass
grafting in 91 patients, mitral valve replacement in 9, aortic
valve replacement in 5, double valve replacement in 4, the
Bentall procedure in 3, replacement of the ascending aorta in
5, and total arch replacement in 2 (Table III). 
Postoperatively, patient management included radial arter-
ial pressure monitoring and use of thermodilution catheters
(Swan-Ganz; Baxter Healthcare Corp, Edwards Division,
Santa Ana, Calif) to measure cardiac index. Most of the
patients received mechanical ventilation overnight and were
extubated on the first day after the operation. All patients with
dialysis-dependent renal insufficiency underwent postopera-
tive hemodialysis on the second day after the operation. 
Perioperative morbidity was defined as one or more of the
following: Cardiac complications (myocardial infarction with
or without low cardiac output) were defined as conditions
that required the use of inotropic agents, intra-aortic balloon
pump support, or ventricular assist device support. (The
patients who received dopamine or dobutamine, or both, in a
dose of more than 5 m g · kg–1 · min–1, those who received epi-
nephrine, or those who required intra-aortic balloon pumping
were considered to have low cardiac output. This definition
was accepted when these therapies were required for longer
than 6 hours.) Rhythm disturbances, identified by the need
for antiarrhythmic therapies for longer than 6 hours, were
also included as postoperative cardiac complications.
Neurologic complications were divided into 2 groups:
stroke and temporary neurologic dysfunction. Postoperative
stroke was defined as any clinically evident focal or general
neurologic deficit that was not present before the operation
but was identified after the operation and new lesions diag-
nosed by computed tomography. Any patients who had not
recovered neurologically from the operation within 48 hours
and who were comatose or semicomatose were included in
the definition of stroke. Temporary neurologic dysfunction
was defined as transient disorientation, agitation, delirium,
and character changes with no neurologic sequelae. 
Respiratory complications were considered to include the
necessity for prolonged postoperative mechanical ventilation
(>24 hours) or the need for reintubation because of a prima-
ry lung failure.
Gastrointestinal complications were defined as the occur-
rence of gastrointestinal bleeding, mesenteric infarction, or
bowel occlusion diagnosed by means of endoscopic evalua-
tion or an abdominal operation. 
Postoperative renal failure was defined as urine output of
less than 400 mL in a 24-hour period, a 50% increase in
serum creatinine from baseline, or institution of hemodialysis
or peritoneal dialysis. Serious infection was defined as the
occurrence of culture-proven pneumonia, mediastinitis,
wound infection, urinary tract infection, or septicemia, with
appropriate clinical findings.
Death in the intensive care unit within 24 hours after the
operation is also included in morbidity because early death
precludes observation of morbidity. Operative mortality was
defined as any death that occurred during the hospitalization.
Any deaths that occurred after discharge from the hospital but
Table III. Operative variables (mean ± SD)
Group I, No. (%) Group II, No. (%) Group III, No. (%) Statistical significance
CABG 70 (75.2) 11 (61.0) 7 (87.5)
CABG + mitral valve 2 (2.1) 1 (5.5) 0 (0.0)
repair
MVR 7 (7.5) 2 (11.1) 0 (0.0)
AVR 4 (4.3) 1 (5.5) 0 (0.0)
Ascending ± arch 7 (7.5) 2 (11.1) 1 (12.5)
operation
AVR + MVR 3 (3.2) 1 (5.5) 0 (0.0)
CPB (min) 96.2 ± 40.3 109.9 ± 56.8 87.9 ± 38.4 c 2 = 1.66, P = .4*
Crossclamp time (min) 67.8 ± 30.9 74.3 ± 31.9 52.4 ± 7.2 c 2 = 3.06, P = .2*
Mediastinal drainage 680.7 ± 405.5 742.8 ± 520.6 655.6 ± 323.1 c 2 = 0.21, P = .9*
(mL)
Blood and blood products 2.4 ± 1.4 2.6 ± 1.8 2.7 ± 1.7 c 2 = 14.5, P = .9*
(unit)
CABG, Coronary artery bypass grafting; MVR, mitral valve replacement; AVR, aortic valve replacement; CPB, cardiopulmonary bypass.
*Kruskal-Wallis test.
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within 30 days of the procedure were included as operative
mortality unless the cause was clearly unrelated to the
operation. The remainder of the deaths were defined as late
mortality.
Statistical analysis. The Kruskal-Wallis test and analysis
of variance for repeated measures were used for the analysis
of continuous data of the 3 groups, and the Wilcoxon
matched-pairs signed-rank test was used for each group. The
Mann-Whitney U test was used for independent groups.
Backward stepwise multivariable logistic regression analysis
was used to identify a number of patient-related preoperative,
operative, and postoperative predictors of mortality and mor-
bidity. A total of 31 variables were studied: 13 were preoper-
ative (preoperative creatinine level, age, gender, body surface
area, presence of hypertension, diabetes mellitus, cerebrovas-
cular disease, peripheral vascular disease, chronic obstructive
pulmonary disease, prior myocardial infarction, angina class,
family history, and long-term dialysis), 8 were operative
(coronary artery bypass surgery, valvular surgery, aortic
surgery, CPB time, crossclamp time, emergency status, peri-
operative excessive mediastinal hemorrhage, and the use of
blood or blood products), and 10 were postoperative (postop-
erative low cardiac output, stroke, transient neurologic
deficit, pulmonary insufficiency, acute renal failure necessi-
tating dialysis, gastrointestinal complication, serious infec-
tion, rhythm disturbances, multiple system organ failure, and
postoperative creatinine level). A contingent probability of
.10 or less was used to enter and .15 to remove the variables
from the model. Postoperative complications were not taken
into account as variables in analyzing postoperative morbidi-
ty. The estimated odds ratio was the likelihood of an event in
the presence of a variable compared with its likelihood in the
absence of that variable. Kaplan-Meier survival analysis was
performed for late mortality for the 3 groups, and the mean
survival times were given with 95% confidence intervals.
SPSS for Windows release 7.5 (SPSS, Inc, Chicago, Ill) was
used for data analysis.
Results
Eighteen patients died in the hospital, for an overall
30-day mortality rate of 15.1%. The causes of death
were cardiac in 10 patients, renal in 3, infectious in 3,
cerebrovascular in 2, pulmonary in 2, and gastrointesti-
nal in 2. The hospital mortality rates for patients in
groups I, II, and III were 11 (11.8%), 6 (33.3%), and 1
(12.5%), respectively (Table IV). On multivariable
analysis, perioperative variables significantly associated
with increased risk for in-hospital mortality were preop-
erative creatinine level greater than 2.5 mg/dL, angina
class III-IV, excessive mediastinal hemorrhage, emer-
gency status, postoperative pulmonary insufficiency, low
cardiac output, and rhythm disturbances (Table V).
Fifty-four postoperative complications were ob-
served in 34 patients, for an early morbidity rate of
28.6%. Complications were cardiac in 20 patients, pul-
monary in 11, infectious in 6, renal in 8, neurologic in
3, and gastrointestinal in 2. Cardiac complications
included arrhythmias in 12 patients and low cardiac
output in 8. Pulmonary complications included respira-
tory failure in 6 patients (2 of them required a tra-
cheostomy), pleural effusion necessitating tube thora-
costomy drainage in 4, and aspiration pneumonia in 1
patient. There were 2 minor leg wound infections, 2
sternal wound infections, 1 urinary tract infection, and
1 case of sepsis syndrome. Neurologic complications
Table IV. Postoperative variables (mean ± SD)
Group I, No. (%) Group II, No. (%) Group III, No. (%) Statistical significance
Mortality 11 (11.8) 6 (33.3) 1 (12.5) c 2 = 3.06, P = .2
Cardiac 6 (54.5) 3 (50.0) 1 (100.0)
Renal 0 (0.0) 3 (50.0) 0 (0.0)
Infectious 2 (18.2) 1 (16.7) 0 (0.0)
Pulmonary 1 (9.1) 1 (16.7) 0 (0.0)
Neurologic 1 (9.1) 1 (16.7) 0 (0.0)
GIS 1 (9.1) 0 (0.0) 0 (0.0)
Morbidity 20 (21.5) 8 (44.4) 6 (75.0) c 2 = 12.947, P = .001
Cardiac 14 (70.0) 3 (37.5) 3 (50.0)
Pulmonary 6 (30.0) 4 (50.0) 1 (16.6)
Renal 2 (10.0) 6 (75.0) 0 (0.0)
Infectious 4 (20.0) 2 (25.0) 0 (0.0)
Neurologic 2 (10.0) 1 (12.5) 0 (0.0)
GIS 2 (10.0) 0 (0.0) 0 (0.0)
Hemorrhage 1 (5.0) 1 (12.5) 0 (0.0)
Other 0 (0.0) 0 (0.0) 2 (33.4)
In-hospital stay (day) 20.0 ± 11.5 26.4 ± 8.8 13.6 ± 3.2 c 2 = 15.3, P = .0005
GIS, Gastrointestinal system.
*Kruskal-Wallis test.
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included strokes in 2 patients and intracerebral hemor-
rhage in 1 patient. Gastrointestinal complications
included bleeding and acute cholecystitis in 1 patient
each. Two patients required reoperation for excessive
mediastinal hemorrhage. The complication directly
related to hemodialysis in our patients was thrombotic
occlusion of a fistula in 2 patients. The hospital mor-
bidity for patients in groups I, II, and III were 20
(21.5%), 8 (44.4%), and 6 (75.0%), respectively (Table
IV). On multivariable analysis with the use of logistic
regression, perioperative variables significantly associ-
ated with increased risk for in-hospital morbidity were
preoperative creatinine level greater than 2.5 mg/dL
and postoperative dialysis (Table V).
The average postoperative drainage for 24 hours was
688.4 ± 31.3 mL. Only 2 patients returned to the oper-
ating room for bleeding. Sites of bleeding were discov-
ered in both patients, so that coagulopathy related to
renal failure was not considered to be the cause. Total
blood product administration during the operation or
within 24 hours after the operation averaged 2.46 ± 1.5
U. In group III, we used an autotransfusion device to
concentrate suctioned mediastinal blood during the
operation. The amounts of postoperative blood loss and
transfusion requirements of the 3 groups were com-
pared. Although the difference was not statistically sig-
nificant (Kruskal-Wallis c 2 test = 14.5, P = .93), the
number of units of red cells transfused was slightly
higher in group III than in the other groups (Table III).
The greater number of units of blood transfused in this
Table V. The predictors of early mortality, morbidity, and postoperative renal failure
Predictive factors P value Odds ratio* (95% CI)
Early mortality
Preoperative Creatinine > 2.5 mg/dL .02 4.58 (1.26-16.72)
Angina class III-IV .02 5.96 (1.94-18.27)
Perioperative Excessive hemorrhage .04 3.98 (1.05-15.09)
Emergency .02 6.45 (1.38-30.08)
Postoperative Pulmonary insufficiency .002 57.75 (11.73-929.91)
Low cardiac output .0001 257.0 (13.38-2733.02)
Infection .06 20.73 (2.21-229.07) 
Rhythm disturbances .01 28.05 (2.26-298.09)
Early morbidity
Preoperative Creatinine > 2.5 mg/dL .003 4.24 (1.61-11.11)
Perioperative CPB > 90 minutes .06 8.81 (1.18-89.27)
Postoperative Dialysis .0002 9.20 (4.13-15.38)
Postoperative acute renal failure
Preoperative Creatinine > 2.5 mg/dL .01 22.93 (1.90-276.00)
Postoperative Infection .0001 356.03 (17.38-7292.01)
Low cardiac output .02 23.83 (1.79-316.01)
Pulmonary insufficiency .02 20.64 (1.62-262.75)
CPB, Cardiopulmonary bypass.
*Multivariable.
Table VI. Differences in creatinine levels
Preoperative Postoperative
Mean ± SD 95% CI Mean ± SD 95% CI Statistical 
Group No. (min-max) for the mean (min-max) for the mean significance*
Group I 93 1.8 ± 0.2 1.8-1.9 1.9 ± 0.5 1.8-2.0 Z = –1.1648
(1.5-2.4) (1.0-4.0) P = .2
Group II 18 3.3 ± 1.0 2.8-3.8 4.0 ± 1.0 3.5-4.5 Z = 2.2211
(2.5-6.1) (2.7-5.6) P = .03
Group III 8 7.6 ± 2.4 5.6-9.7 6.7 ± 2.7 4.4-9.0 Z = –1.4201
(5.2-11.3) (3.7-11.6) P = .7
Total 119 2.4 ± 1.7 2.1-2.7 2.6 ± 1.6 2.3-2.9 Z = –1.754
(1.5-11.3) (1.0-11.6) P = .08 
*Wilcoxon matched-pairs signed-rank test.
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group was not due to greater postoperative blood loss.
There were no significant differences between the
groups in terms of CPB time, crossclamp time, and the
amount of postoperative blood loss (Table III). 
An analysis of the mean creatinine values in group I
patients on admission and in the postoperative period
showed a minimal and nonsignificant increase from 1.8
± 0.2 mg/dL to 1.9 ± 0.5 mg/dL. Only 2 patients in this
group required postoperative dialysis (2.2%). In group
II the mean preoperative creatinine value was 3.3 ± 1.0
mg/dL. After the operation this value increased signifi-
cantly to 4.0 ± 1.0 mg/dL (Table VI). Six patients in
group II required postoperative dialysis (33.3%). In
groups I and II, multivariable analysis was used for
identifying perioperative risk factors for postoperative
acute renal failure necessitating dialysis. Preoperative
creatinine level greater than 2.5 mg/dL, postoperative
pulmonary insufficiency, low cardiac output, and seri-
ous infection were found to be independent predictors
(Table V). In group III, postoperative mean creatinine
value was found to be slightly lower than the preoper-
ative value (7.6 ± 2.4 vs 6.7 ± 2.7 mg/dL) (Fig 1). 
For the 101 patients who were discharged from the
hospital, the average length of stay in the hospital for
Fig 1. Changes in serum creatinine after CPB. In patients in group II, differences between preoperative and post-
operative levels were statistically significant (Wilcoxon test).
Table VII. Morbidity and mortality of cardiac surgery in the different series of patients having dialysis 
Morbidity Mortality
First author Year No. of patients No. % No. %
Marshall16 1986 12 2 16.7 1 8.3
Laws7 1986 10 6 60.0 1 10.0
Blakeman17 1989 21 15 71.4 2 9.5
Ko18 1993 25 18 72.0 4 16.0
Kaul19 1994 35 23 65.7 4 11.4
Owen20 1994 21 10 47.6 2 9.5
Samuels11 1996 13 10 76.9 4 30.8
Present study 8 6 75.0 1 12.5
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patients in groups I, II, and III were 20.02 ± 11.46 days
(6-71 days), 26.42 ± 8.77 days (15-45 days), and 13.57
± 3.15 days (10-19 days), respectively (Kruskal Wallis
test c 2 = 15.3, P = .0005). 
There was no significant differences between the
average length of hospital stay of group I and group III
patients (U = 175, P = .089). Follow-up was complete
in all hospital survivors (n = 101), with a mean follow-
up of 34.8 ± 16.4 months (3-67 months). Follow-up
information was obtained on all patients by direct tele-
phone contact or clinical examination. There were 9
late deaths (8.9%). The causes of death were cardiac in
4 patients, renal in 2, pulmonary in 1, and unknown in
2 patients. The late mortality rates for patients in
groups I, II, and III were 6.1%, 25%, and 14.3%,
respectively. The mean survival times are different for
each of the 3 groups. Although the long-term survival
is reduced in group II patients, it is difficult to interpret
the results because of the small sample sizes of the sec-
ond and the third groups and the number of deaths in
the groups (Fig 2). 
Conclusion
Cardiac disease continues to be a major cause of death
in patients with CRF and is responsible for up to 60%
of all causes of death.14,15 It has been stated that athero-
sclerosis is accelerated in patients undergoing long-term
hemodialysis. Hyperlipidemia, hypertension, renal ane-
Fig 2. Comparison of survival curves in patients with different stages of renal failure (standard deviations are
given in parentheses).
Table VIII. Morbidity and mortality of patients with non–dialysis-dependent renal insufficiency
Morbidity MortalityCreatinine level 
First author Year (mg/dL) No. of patients No. % No. %
Zanardo23 1994 >1.5 41 13 31.7* 7 17.1
Samuels11 1996 ‡ 1.6 31 25 80.6† 6 19.3
Rao12 1997 >1.7 38 19 50.0‡ 2 5.3
Present study >1.6 111 28 25.2† 17 15.3
*Only cardiac morbidity.
†Total morbidity.
‡Cardiac and renal morbidity.
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mia, increased volume load caused by arteriovenous
shunts, platelet dysfunction, and abnormalities in the
metabolism of calcium and triglycerides are main fac-
tors that increase the incidence of cardiac diseases.
Patients requiring long-term hemodialysis are known to
be at a high risk for both mortality and morbidity during
heart surgery. In the literature, morbidity in different
series ranged from 17% to 77%. In most of these series,
morbidity was 60% or higher. Mortality in these series
ranged from 8% to 31%.7,11,16-20 Our morbidity and
mortality were 75.0% and 12.5%, respectively (Table
VII). Despite this increased risk, long-term studies have
demonstrated a benefit of surgical revascularization
over percutaneous transluminal coronary angioplasty in
both overall survival and angina-free survival.21 Kahn
and associates22 found that the restenosis rate is higher
in patients undergoing dialysis than in the routine popu-
lation undergoing coronary angioplasty.
End-stage renal failure has been viewed as an impor-
tant preoperative predictor of surgical outcome; howev-
er, the impact of renal impairment on the results of heart
surgery has been somewhat ill defined. Ideally, creati-
nine clearance should be used to assess risk, because
serum creatinine levels are dependent on body size and
state of hydration. However, serum creatinine levels can
be used as an adequate indicator of renal function. Thus
mild elevation of serum creatinine may reflect a signifi-
cant impairment of renal function. For practical purpos-
es, we used the serum creatinine levels taken from the
patients. There is considerably less information in the
literature about operative morbidity and mortality in
patients with CRF who are not undergoing dialysis. A
limited number of series show that morbidity ranged
from 32% to 80% and mortality ranged from 5% to
19%.11,12,23 Our morbidity and mortality were 25.2%
and 15.3%, respectively, in patients with non–dialysis-
dependent renal insufficiency (Table VIII).
In patients with CRF the preoperative, intraoperative,
and postoperative care are important. In our practice,
all patients with dialysis-dependent renal insufficiency
underwent preoperative hemodialysis within 24 hours
of the operation, the second day after the operation, and
then according to their preoperative routine or as dic-
tated by the nephrologist. We prefer peritoneal dialysis
if the hemodynamics of the patient is unstable. None of
the patients in group III required postoperative peri-
toneal dialysis.
The serum potassium level was corrected to the range
of 3.5 to 5.0 mmol/L. The patients were given blood
transfusions before the operation if the hematocrit
value was lower than 25%. Cephalosporins were given
for antibiotic prophylaxis. The patients were taken to
the operating room with optimal hydration and elec-
trolyte balance. Myocardial depressants were avoided,
and minimal intravenous fluids, consisting of 5% dex-
trose in water, were administered. The use of intra-
operative hemodialysis was advocated by some
groups.24,25 Intraoperative ultrafiltration is valuable in
removing excess plasma water during CPB. It also
avoids the hemodynamic instability and the risk of
heparin-associated bleeding associated with the use of
hemodialysis. We used continuous hemodiafiltration
during and after CPB in all dialysis-dependent patients,
and we did not see any complication related to this pro-
cedure. The chronic anemia and platelet function dis-
turbances may obligate them to a greater requirement
for transfusion of blood products in the perioperative
period. In dialysis-dependent patients we used an auto-
transfusion device to concentrate suctioned mediastinal
blood during the operation. In our study, the blood
product requirements of dialysis-dependent patients
with renal failure were slightly greater than those of
non–dialysis-dependent patients. The greater number
of units of red cells used possibly reflected more intra-
operative usage, which was due to lower preoperative
hematocrit levels in these patients. The chronic arteri-
ovenous fistulas of patients with end-stage CRF are at
risk for thrombosis during the operation, probably from
low peripheral perfusion during CPB or applied pres-
sure to the fistula during arm positioning. In group III,
2 of 8 patients had this complication. In both of these
patients, hemodialysis was performed with a temporary
hemodialysis catheter inserted through the subclavian
vein. Revisions of fistulas were made before discharge.
Inasmuch as dialysis access sites are finite, the arteri-
ovenous fistulas should be protected carefully by prop-
er positioning. 
Regular estimation of the acid-base balance and elec-
trolyte concentrations is essential during the postoper-
ative period for detecting and treating abnormalities.
Assessment of tissue perfusion and measurements of
daily weights, blood pressure, pulse rate, and central
venous pressure are mandatory for correct manage-
ment. The most important electrolyte imbalance in
CPB operations is that of potassium, because elevated
and reduced levels are associated with life-threatening
arrhythmia, especially after ischemia. In our study,
ventricular arrhythmia and fibrillation were common
causes of morbidity in dialysis-dependent patients and
were responsible for 50% (3 patients) of all causes of
morbidity. Fluid restriction is essential in patients with
long-term hemodialysis. In non–dialysis-dependent
patients, volume replacement must be according to
urine output. In these patients, excessive fluid restric-
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tion may cause acute renal failure. We applied routine
administration of dopamine hydrochloride in patients
with serum creatinine levels of more than 1.6 mg/dL
and took aggressive measures to assure adequate
hydration and to maintain urine output during the oper-
ation. Postoperative early hemodialysis may be useful
in patients with inadequate urine output and a high
potassium level. In patients in group I or II, we used
some criteria for initiating dialysis. Dialysis was insti-
tuted whenever a 50% increase in serum creatinine
from baseline was observed or the patient exhibited
inadequate urine output (<400 mL for 24 hours) despite
correction of hemodynamic status and diuretic therapy,
especially if fluid overload, hyperkalemia, or metabol-
ic acidosis was also present. If hemodynamic status
was not stable, peritoneal dialysis was commenced
(4/111 patients in groups I and II).
The use of peritoneal dialysis has some advantages
over hemodialysis in the early postoperative period.
Peritoneal dialysis can be initiated with minimal equip-
ment and does not require specialized personnel. It also
avoids the potential complications of abrupt hemody-
namic changes or the risk of heparin-associated bleed-
ing that may occur with the use of hemodialysis.
Peritoneal dialysis allows a prolonged delay in the rein-
stitution of hemodialysis. Especially in group II
patients, early institution of peritoneal dialysis may be
of great benefit. However, peritoneal dialysis may be
contraindicated when there is continuity of the thorax
or pericardium (or both) with the abdominal cavity.
Risks of peritonitis, respiratory disturbances, and pro-
tein loss are other drawbacks of the peritoneal dialysis.
In patients with moderate elevation of serum creati-
nine levels (1.6 mg/dL through 2.5 mg/dL), there is less
probability of postoperative dialysis, but preoperative
values of greater than 2.5 mg/dL are associated with a
markedly increased risk. Accordingly, in group I, 2 of
93 patients needed postoperative dialysis (2.2%),
whereas 6 patients in group II progressed to dialysis
during the hospital course (33%) (P = .003). Hemo-
dialysis was performed in 4 of them. The remaining 4
patients were entered into the peritoneal dialysis pro-
gram because of hemodynamic instability. It is clear
that the status of patients with CFR worsened after
CPB, particularly in those with creatinine values high-
er than 2.5 mg/dL. CPB in patients with CRF poses a
special problem because of the excessive fluid shifts in
the different body compartments during CPB. With
reduced renal capacity, the tolerance to CPB is wors-
ened. The outcome of the operation depends in part on
the ability of the kidneys to deal with those fluid shifts.
Group II patients seem more susceptible to the adverse
effect of CPB because they have more advanced com-
promise of renal function than the group I patients.
At present, the overall mortality of cardiac surgery
with CPB is 3.5% at our clinic. This represents less
than one fourth of the mortality in patients with CRF
(15.1%). The incidence of mortality was also consider-
ably higher in patients with preoperative creatinine lev-
els greater than 2.5 mg/dL (33%). Especially in groups
II and III, the postoperative course was complicated in
most cases. In patients with non–dialysis-dependent
renal failure, when postoperative renal failure is severe
enough to require dialysis, morbidity and mortality are
markedly increased despite dialysis and intensive sup-
portive care. In addition to problems in the manage-
ment of fluid and electrolytes, a number of comorbid
factors such as low cardiac output state, bleeding
diathesis, and susceptibility to infection predispose
these patients to increased operative morbidity and
mortality. In 6 patients in group II, the postoperative
period was complicated by acute renal failure necessi-
tating dialysis, and 4 of the patients died. In patients
with preoperative renal failure with long-term
hemodialysis, when dialysis is performed the day
before and then the normal dialysis routine is resumed
on the second postoperative day, the renal management
of these patients is straightforward. In group III, all
patients were in hemodynamically stable condition in
the early postoperative period and none of them need-
ed inotropic agents or peritoneal dialysis immediately
after the operation. In group III patients CPB proce-
dures were performed with a good operative outcome.
Because major morbidity that necessitates longer hos-
pitalization was more common in group II patients, the
average hospitalization time was significantly longer
when compared with that of group III patients. Group
III patients are under the care of a nephrologist for a
long time and no additional preoperative evaluation is
needed in these patients, but preoperative diagnostic
facilities and consultations cause longer preoperative
stays in group II patients. 
In conclusion, the patients with CRF with significant
comorbid diseases should be evaluated carefully.
Preoperative renal failure increases the mortality and
morbidity in patients undergoing heart surgery. Our
results suggest that even those patients with relatively
mild renal insufficiency remain at risk for a poor out-
come. In patients with creatinine levels higher than 2.5
mg/dL, there is a strong likelihood of postoperative
dialysis besides increased risks of mortality and mor-
bidity. It is important to develop methods of identifying
patients at high risk for perioperative renal failure
because renal ischemia is generally silent, unlike
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ischemia of the coronary, cerebral, and peripheral vas-
cular beds, which are usually overt, manifested by angi-
na pectoris, neurologic sequelae, and claudication,
respectively. Reduced baseline renal function can be
used to stratify patients before surgery and to identify
several subgroups of patients at substantially increased
risk. A prospective randomized trial is required to
assess the long-term results of heart surgery in patients
with different stages of renal failure. In group II
patients, correct evaluation of the necessity of dialysis
and proper timing to start it will be a major concern of
future studies. 
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